The impact of cumulative colorectal cancer screening delays: A simulation study

CM Rutter, JM Inadomi… - Journal of medical …, 2022 - journals.sagepub.com
Objective Annual fecal immunochemical tests can reduce colorectal cancer incidence and
mortality. However, screening is a multi-step process and most patients do not perfectly …

Consequences of increasing time to colonoscopy examination after positive result from fecal colorectal cancer screening test

RGS Meester, AG Zauber, CA Doubeni… - Clinical …, 2016 - Elsevier
Background & Aims Delays in diagnostic testing after a positive result from a screening test
can undermine the benefits of colorectal cancer (CRC) screening, but there are few …

Calculation of stop ages for colorectal cancer screening based on comorbidities and screening history

DR Cenin, J Tinmouth, SK Naber, C Dubé… - Clinical …, 2021 - Elsevier
Background & Aims Routine screening for colorectal cancer typically is recommended until
age 74 years. Although it has been proposed that a screening stop age could be determined …

Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force

AB Knudsen, CM Rutter, EFP Peterse, AP Lietz… - Jama, 2021 - jamanetwork.com
Importance The US Preventive Services Task Force (USPSTF) is updating its 2016
colorectal cancer screening recommendations. Objective To provide updated model-based …

Association of reducing the recommended colorectal cancer screening age with cancer incidence, mortality, and costs in Canada using OncoSim

A Kalyta, Y Ruan, JJ Telford, MA De Vera… - JAMA …, 2023 - jamanetwork.com
Importance Recent US guideline updates have advocated for colorectal cancer (CRC)
screening to begin at age 45 years in average-risk adults, whereas Canadian screening …

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer

T Dinh, U Ladabaum, P Alperin, C Caldwell… - Clinical …, 2013 - Elsevier
Background & Aims Colorectal cancer (CRC) screening guidelines recommend screening
schedules for each single type of test except for concurrent sigmoidoscopy and fecal occult …

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening

SL Goede, L Rabeneck, M van Ballegooijen… - PloS one, 2017 - journals.plos.org
Background The ColonCancerCheck screening program for colorectal cancer (CRC) in
Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test …

Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force

AB Knudsen, AG Zauber, CM Rutter, SK Naber… - Jama, 2016 - jamanetwork.com
Importance The US Preventive Services Task Force (USPSTF) is updating its 2008
colorectal cancer (CRC) screening recommendations. Objective To inform the USPSTF by …

Colorectal cancer screening within colonoscopy capacity constraints: can FIT-based programs save more lives by trading off more sensitive test cutoffs against longer …

E McFerran, JF O'Mahony, S Naber… - MDM Policy & …, 2022 - journals.sagepub.com
Introduction. Colorectal cancer (CRC) prevention programs using fecal immunochemical
testing (FIT) in screening rely on colonoscopy for secondary and surveillance testing …

Screening for colorectal cancer with fecal immunochemical testing with and without postpolypectomy surveillance colonoscopy: a cost-effectiveness analysis

MJE Greuter, CM De Klerk, GA Meijer… - Annals of internal …, 2017 - acpjournals.org
Background: Population-based screening to prevent colorectal cancer (CRC) death is
effective, but the effectiveness of postpolypectomy surveillance is unclear. Objective: To …